Evidence map›Paper›PMID 36376382›Full record

ArticleCell death and differentiation2023

A BAK subdomain that binds mitochondrial lipids selectively and releases cytochrome C.

Haiming Dai, Kevin L Peterson, Karen S Flatten, X Wei Meng, Annapoorna Venkatachalam, Cristina Correia, Marina Ramirez-Alvarado, Yuan-Ping Pang, Scott H Kaufmann

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Mitochondrial metabolism and cancer therapeutic innovation.Signal transduction and targeted therapy · 2025
    Review
  6. Article
  7. Review
  8. Prohibitions in the meta-inflammatory response: a review.Frontiers in molecular biosciences · 2024
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Haiming Dai *Division of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA. Dai.Haiming@Mayo.edu.ORCID 0000-0002-0484-7407
Kevin L PetersonDivision of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.
Karen S FlattenDivision of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.
X Wei MengDivision of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.
Annapoorna VenkatachalamDivision of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.
Cristina CorreiaDivision of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.ORCID 0000-0002-9464-7555
Marina Ramirez-AlvaradoDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA.ORCID 0000-0003-2325-6773
Yuan-Ping PangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.ORCID 0000-0003-0838-2560
Scott H Kaufmann *Division of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA. Kaufmann.Scott@Mayo.edu.ORCID 0000-0002-4900-7145
Mayo Clinic · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
BAK Autoactivation in Hematological MalignanciesR01CA225996 · NCI · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H · 2020 to 2024
$1.8M
Anticancer drug-induced BH3-only protein.Bak interactionsR01CA166741 · NCI · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H · 2012 to 2016
$1.6M
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA166741NCI NIH HHS R01 CA225996
6 · The paper itself

Abstract

How BAK and BAX induce mitochondrial outer membrane (MOM) permeabilization (MOMP) during apoptosis is incompletely understood. Here we have used molecular dynamics simulations, surface plasmon resonance, and assays for membrane permeabilization in vitro and in vivo to assess the structure and function of selected BAK subdomains and their derivatives. Results of these studies demonstrate that BAK helical regions α5 and α6 bind the MOM lipid cardiolipin. While individual peptides corresponding to these helical regions lack the full biological activity of BAK, tandem peptides corresponding to α4-α5, α5-α6, or α6-α7/8 can localize exogenous proteins to mitochondria, permeabilize liposomes composed of MOM lipids, and cause MOMP in the absence of the remainder of the BAK protein. Importantly, the ability of these tandem helices to induce MOMP under cell-free conditions is diminished by mutations that disrupt the U-shaped helix-turn-helix structure of the tandem peptides or decrease their lipid binding. Likewise, BAK-induced apoptosis in intact cells is diminished by CLS1 gene interruption, which decreases mitochondrial cardiolipin content, or by BAK mutations that disrupt the U-shaped tandem peptide structure or diminish lipid binding. Collectively, these results suggest that BAK structural rearrangements during apoptosis might mobilize helices involved in specific protein-lipid interactions that are critical for MOMP.

Indexed as

CardiolipinsCytochromes cApoptosisbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinMitochondriaMitochondrial Membranesbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinCardiolipinsCytochromes c

Identifiers

PMID36376382
PMCPMC9984382
OpenAlexW4308970066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.